Innocan Pharma Corporation Appoints Richard Serbin to its Advisory Committee
April 07, 2021 at 01:43 am IST
Innocan Pharma Corporation announced the addition of Richard Serbin to its Advisory Committee. Richard Serbin will work closely with Innocan's leadership to address the emerging global Pharma opportunities, to expand Innocan's presence as part of its growth strategy, and to contribute from his extensive experience as Johnson & Johnson's Executive Vice President of Corporate Development, as former board member of more than 16 companies and, especially in regard to FDA regulations.